English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/160082
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Proteomic characterization of transcription and splicing factors associated with a metastatic phenotype in colorectal cancer

Otros títulosTranscription factors in metastatic colorectal cancer [Running title]
AutorTorres, Sofía ; García-Palmero, Irene ; Marín-Vicente, Consuelo; Bartolomé, Rubén Álvaro ; Calviño, Eva ; Fernandez-Aceñero, M. Jesús; Casal, J. Ignacio
Palabras claveSRSF3
Transcription factors
Splicing factors
Metastasis
Colorectal cancer
Fecha de publicación5-ene-2018
EditorAmerican Chemical Society
CitaciónJ Proteome Res 17(1):252-264 (2018)
ResumenWe investigated new transcription and splicing factors associated with the metastatic phenotype in colorectal cancer. A concatenated tandem array of consensus transcription factor (TF)-response elements was used to pull down nuclear extracts in two different pairs of colorectal cancer cells, KM12SM/KM12C and SW620/480, genetically related but differing in metastatic ability. Proteins were analyzed by label-free LC-MS and quantified with MaxLFQ. We found 240 proteins showing a significant dysregulation in highly metastatic KM12SM cells relative to nonmetastatic KM12C cells and 257 proteins in metastatic SW620 versus SW480. In both cell lines there were similar alterations in genuine TFs and components of the splicing machinery like UPF1, TCF7L2/TCF-4, YBX1, or SRSF3. However, a significant number of alterations were cell-line specific. Functional silencing of MAFG, TFE3, TCF7L2/TCF-4, and SRSF3 in KM12 cells caused alterations in adhesion, survival, proliferation, migration, and liver homing, supporting their role in metastasis. Finally, we investigated the prognostic value of the altered TFs and splicing factors in cancer patients. SRSF3 and SFPQ showed significant prognostic value. We observed that SRSF3 displayed a gradual loss of expression associated with cancer progression. Loss of SRSF3 expression was significantly associated with poor survival and shorter disease-free survival, particularly in early stages, in colorectal cancer.
Descripción44 p.-7 fig.
Versión del editorhttp://dx.doi.org/10.1021/acs.jproteome.7b00548
URIhttp://hdl.handle.net/10261/160082
DOI10.1021/acs.jproteome.7b00548
ISSN1535-3893
E-ISSN1535-3907
Aparece en las colecciones: (CIB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
JPR _Proteomic characterization_2018.pdf Embargado hasta 5 de enero de 2019Postprint1,67 MBAdobe PDFVista previa
Visualizar/Abrir     Petición de una copia
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.